PTKFY
Price
$18.45
Change
-$1.05 (-5.38%)
Updated
Jul 8 closing price
Capitalization
5.53B
SNPHY
Price
$11.39
Change
+$0.09 (+0.80%)
Updated
Jul 25 closing price
Capitalization
3.26B
Interact to see
Advertisement

PTKFY vs SNPHY

Header iconPTKFY vs SNPHY Comparison
Open Charts PTKFY vs SNPHYBanner chart's image
PT Kalba Farma TBK
Price$18.45
Change-$1.05 (-5.38%)
Volume$240
Capitalization5.53B
Santen Pharmaceutical
Price$11.39
Change+$0.09 (+0.80%)
Volume$730
Capitalization3.26B
PTKFY vs SNPHY Comparison Chart in %
Loading...
PTKFY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PTKFY vs. SNPHY commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTKFY is a Hold and SNPHY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (PTKFY: $18.45 vs. SNPHY: $11.39)
Brand notoriety: PTKFY and SNPHY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: PTKFY: 70% vs. SNPHY: 14%
Market capitalization -- PTKFY: $5.53B vs. SNPHY: $3.26B
PTKFY [@Pharmaceuticals: Major] is valued at $5.53B. SNPHY’s [@Pharmaceuticals: Major] market capitalization is $3.26B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PTKFY’s FA Score shows that 2 FA rating(s) are green whileSNPHY’s FA Score has 0 green FA rating(s).

  • PTKFY’s FA Score: 2 green, 3 red.
  • SNPHY’s FA Score: 0 green, 5 red.
According to our system of comparison, PTKFY is a better buy in the long-term than SNPHY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PTKFY’s TA Score shows that 3 TA indicator(s) are bullish while SNPHY’s TA Score has 4 bullish TA indicator(s).

  • PTKFY’s TA Score: 3 bullish, 3 bearish.
  • SNPHY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SNPHY is a better buy in the short-term than PTKFY.

Price Growth

PTKFY (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while SNPHY (@Pharmaceuticals: Major) price change was +0.71% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +3.43%. For the same industry, the average monthly price growth was +7.37%, and the average quarterly price growth was +13.00%.

Industries' Descriptions

@Pharmaceuticals: Major (+3.43% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTKFY($5.53B) has a higher market cap than SNPHY($3.26B). PTKFY has higher P/E ratio than SNPHY: PTKFY (30.03) vs SNPHY (15.60). SNPHY YTD gains are higher at: 12.549 vs. PTKFY (-8.848). PTKFY has higher annual earnings (EBITDA): 4.85T vs. SNPHY (17.2B). PTKFY has more cash in the bank: 3.63T vs. SNPHY (62.3B). SNPHY has less debt than PTKFY: SNPHY (40.1B) vs PTKFY (889B). PTKFY has higher revenues than SNPHY: PTKFY (29.79T) vs SNPHY (270B).
PTKFYSNPHYPTKFY / SNPHY
Capitalization5.53B3.26B169%
EBITDA4.85T17.2B28,209%
Gain YTD-8.84812.549-71%
P/E Ratio30.0315.60192%
Revenue29.79T270B11,032%
Total Cash3.63T62.3B5,822%
Total Debt889B40.1B2,217%
FUNDAMENTALS RATINGS
PTKFY vs SNPHY: Fundamental Ratings
PTKFY
SNPHY
OUTLOOK RATING
1..100
5052
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
60
Fair valued
PROFIT vs RISK RATING
1..100
95100
SMR RATING
1..100
14100
PRICE GROWTH RATING
1..100
5054
P/E GROWTH RATING
1..100
8090
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PTKFY's Valuation (24) in the null industry is somewhat better than the same rating for SNPHY (60). This means that PTKFY’s stock grew somewhat faster than SNPHY’s over the last 12 months.

PTKFY's Profit vs Risk Rating (95) in the null industry is in the same range as SNPHY (100). This means that PTKFY’s stock grew similarly to SNPHY’s over the last 12 months.

PTKFY's SMR Rating (14) in the null industry is significantly better than the same rating for SNPHY (100). This means that PTKFY’s stock grew significantly faster than SNPHY’s over the last 12 months.

PTKFY's Price Growth Rating (50) in the null industry is in the same range as SNPHY (54). This means that PTKFY’s stock grew similarly to SNPHY’s over the last 12 months.

PTKFY's P/E Growth Rating (80) in the null industry is in the same range as SNPHY (90). This means that PTKFY’s stock grew similarly to SNPHY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PTKFYSNPHY
RSI
ODDS (%)
Bearish Trend 3 days ago
25%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
35%
Bearish Trend 3 days ago
65%
Momentum
ODDS (%)
Bullish Trend 3 days ago
41%
Bullish Trend 3 days ago
69%
MACD
ODDS (%)
Bearish Trend 3 days ago
25%
Bearish Trend 7 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
24%
Bullish Trend 3 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
22%
Bullish Trend 3 days ago
62%
Advances
ODDS (%)
Bullish Trend 26 days ago
25%
Bullish Trend 14 days ago
57%
Declines
ODDS (%)
N/A
Bearish Trend 18 days ago
66%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
57%
Bullish Trend 3 days ago
68%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
PTKFY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMFGX469.385.64
+1.22%
Vanguard S&P Mid-Cap 400 Growth Idx I
GCSSX25.600.14
+0.55%
Goldman Sachs Small Cap Eq Insghts Svc
RLBGX37.230.08
+0.22%
American Funds American Balanced R6
RGIVX14.55-0.01
-0.07%
ClearBridge Global Infrastructure Inc I
COSSX13.65-0.03
-0.22%
Columbia Overseas Value Inst2

PTKFY and

Correlation & Price change

A.I.dvisor tells us that PTKFY and SNPHF have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTKFY and SNPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTKFY
1D Price
Change %
PTKFY100%
N/A
SNPHF - PTKFY
6%
Poorly correlated
N/A
RHHBF - PTKFY
6%
Poorly correlated
-5.37%
SNPHY - PTKFY
0%
Poorly correlated
+0.80%
OTSKF - PTKFY
0%
Poorly correlated
N/A
RCDTF - PTKFY
0%
Poorly correlated
N/A
More

SNPHY and

Correlation & Price change

A.I.dvisor tells us that SNPHY and SNPHF have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNPHY and SNPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPHY
1D Price
Change %
SNPHY100%
+0.80%
SNPHF - SNPHY
7%
Poorly correlated
N/A
RHHVF - SNPHY
7%
Poorly correlated
-1.03%
RHHBF - SNPHY
6%
Poorly correlated
-5.37%
RHHBY - SNPHY
5%
Poorly correlated
-1.09%
OTSKY - SNPHY
4%
Poorly correlated
+2.15%
More